Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
AST Enzymes is a U.S.-based private manufacturer and marketer of systemic and digestive enzyme supplements focused on gut, digestive, immune, cardiovascular, respiratory, joint, and general wellness applications. The company describes itself as a research-driven enzyme and probiotics manufacturer that formulates and manufactures products in-house rather than only encapsulating or bottling third-party ingredients. Its portfolio includes branded nutritional supplements such as Serracor-NK, Excellacor, Vida-Defense, ImmunoSEB, digestive enzymes, probiotic products, and single-ingredient enzyme formulations like serrapeptase and nattokinase. AST Enzymes appears to operate in the healthcare and nutrition/nutraceutical segment rather than as a drug-development biotech, with products sold commercially to healthcare professionals and consumers. It also indicates private-label and contract manufacturing capabilities supported by GMP/NSF-certified operations and certified laboratory infrastructure.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on AST Enzymes.